Inventor · disambiguated record
Nicolas Bruneau-Latour
Also filed as: BRUNEAU-LATOUR NICOLAS
6 granted patents·2 pending applications·9 citations·filing 2016–2023
76Inventor score
Top patents by PatentIndex Score
8 records- 0189US11739096B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo [1,5-A]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2022·Granted Aug 29, 2023·1 cites·2 claims
- 0281US11230546B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2018·Granted Jan 25, 2022·2 cites·20 claims
- 0379US12486276B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2023·Granted Dec 2, 2025·0 cites·6 claims
- 0479US11325903B2Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseasesBANTAM PHARMACEUTICAL LLC·Filed 2017·Granted May 10, 2022·2 cites·24 claims
- 0578US11602526B2Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating theretoBANTAM PHARMACEUTICAL LLC·Filed 2020·Granted Mar 14, 2023·1 cites·27 claims
- 0677US10537558B2Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating theretoBANTAM PHARMACEUTICAL LLC·Filed 2016·Granted Jan 21, 2020·3 cites·28 claims
- 0770US2022235055A15-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo [1,5-a]pyrimidine derivatives and related compounds as trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0864US2023076820A1Substituted Pyrazole Compounds and Methods of Using Them for Treatment of Hyperproliferative DiseasesBANTAM PHARMACEUTICAL LLC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicolas Bruneau-Latour files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →